[[abstract]]Objectives: To develop algorithms of locating patients with primary aldosteronism (PA) using insurance reimbursement data and to validate the algorithms using medical charts. Study Design and Setting: We extracted National Health Insurance (NHI) reimbursement data and medical charts in seven enrolled hospitals and analyzed diagnosis-related information for 1999-2010. The NHI codes PA as 255.1x, using the International Classification of Diseases, Ninth Revision, Clinical Modification. Confirmation of PA was based on suppression tests. Results: We reviewed medical charts for 1,094 cases with at least one PA diagnosis. PA was confirmed for 563 cases. Compared with patients with essential hypertension, PA patients had higher systoli...
CONTEXT: For health care planning and allocation of resources, realistic estimation of the prevalenc...
ObjectivesWe prospectively investigated the prevalence of curable forms of primary aldosteronism (PA...
OBJECTIVE: Primary aldosteronism (PA) is a potentially curable cause of hypertension associated with...
[[abstract]]Objectives: To develop algorithms of locating patients with primary aldosteronism (PA) u...
Abstract Background Management of primary aldosteronism (PA) has become a research hotspot in the fi...
Objective: Primary aldosteronism (PA) is one of the most frequent causes of secondary hypertension. ...
Primary aldosteronism (PA) is a common form of endocrine hypertension previously believed to account...
Objectives: We prospectively investigated the prevalence of curable forms of primary aldosteronism (...
Background/Purpose: Even with the increasing recognition of primary aldosteronism (PA) as a cause of...
Objective: To develop clinical practice guidelines for the management of patients with primary aldos...
Objective: To assess the identification of primary aldosteronism (PA) in newly diagnosed, treatment-...
OBJECTIVES We prospectively investigated the prevalence of curable forms of primary aldosteronism (P...
OBJECTIVE Primary aldosteronism (PA) is the most common endocrine form of arterial hypertension. Th...
Approximately 29% of Korean adults have hypertension; however, the prevalence of primary aldosteroni...
Objective: The aldosterone-to-renin ratio is widely used and is the recommended screening modality f...
CONTEXT: For health care planning and allocation of resources, realistic estimation of the prevalenc...
ObjectivesWe prospectively investigated the prevalence of curable forms of primary aldosteronism (PA...
OBJECTIVE: Primary aldosteronism (PA) is a potentially curable cause of hypertension associated with...
[[abstract]]Objectives: To develop algorithms of locating patients with primary aldosteronism (PA) u...
Abstract Background Management of primary aldosteronism (PA) has become a research hotspot in the fi...
Objective: Primary aldosteronism (PA) is one of the most frequent causes of secondary hypertension. ...
Primary aldosteronism (PA) is a common form of endocrine hypertension previously believed to account...
Objectives: We prospectively investigated the prevalence of curable forms of primary aldosteronism (...
Background/Purpose: Even with the increasing recognition of primary aldosteronism (PA) as a cause of...
Objective: To develop clinical practice guidelines for the management of patients with primary aldos...
Objective: To assess the identification of primary aldosteronism (PA) in newly diagnosed, treatment-...
OBJECTIVES We prospectively investigated the prevalence of curable forms of primary aldosteronism (P...
OBJECTIVE Primary aldosteronism (PA) is the most common endocrine form of arterial hypertension. Th...
Approximately 29% of Korean adults have hypertension; however, the prevalence of primary aldosteroni...
Objective: The aldosterone-to-renin ratio is widely used and is the recommended screening modality f...
CONTEXT: For health care planning and allocation of resources, realistic estimation of the prevalenc...
ObjectivesWe prospectively investigated the prevalence of curable forms of primary aldosteronism (PA...
OBJECTIVE: Primary aldosteronism (PA) is a potentially curable cause of hypertension associated with...